MALAT1 and neoplasm: Moreover, miR-101-3p plays a critical role in overcoming therapy resistance, as it counteracts the tumor-enhancing effects of MALAT1, a long noncoding RNA associated with increased survival and radioresistance in colorectal cancer cells [40].